Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use case

Cigarette smoking causes major preventable diseases, morbidity, and mortality worldwide. Smoking cessation and prevention of smoking initiation are the preferred means for reducing these risks. Less harmful tobacco products, termed modified-risk tobacco products (MRTP), are being developed as a pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlage, Walter K., Titz, Bjoern, Iskandar, Anita, Poussin, Carine, Van der Toorn, Marco, Wong, Ee Tsin, Pratte, Pascal, Maeder, Serge, Schaller, Jean-Pierre, Pospisil, Pavel, Boue, Stephanie, Vuillaume, Grégory, Leroy, Patrice, Martin, Florian, Ivanov, Nikolai V., Peitsch, Manuel C., Hoeng, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Novel nicotine-delivering products: toxicology, regulation and health issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502378/
https://www.ncbi.nlm.nih.gov/pubmed/32995294
http://dx.doi.org/10.1016/j.toxrep.2020.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502378/
https://www.ncbi.nlm.nih.gov/pubmed/32995294
http://dx.doi.org/10.1016/j.toxrep.2020.09.004

Ejemplares similares